Keystone Advisory delivers rigorous health economic analysis, outcomes research, and strategic counsel for life sciences organizations navigating complex payer and regulatory environments.
Start a conversationKeystone Advisory is an independent health economics and outcomes research consultancy founded by Eric Stone, MHS. With deep expertise in cost-effectiveness modeling, real-world evidence, and health data strategy, Keystone helps life sciences organizations build the evidence base that matters to payers, regulators, and clinicians.
Grounded in academic rigor and sharpened through years of industry experience spanning health systems, technology, and pharma, Keystone delivers analysis that is transparent, defensible, and decision-ready.
Decision-analytic models — Markov, partitioned survival, and beyond — built to withstand payer scrutiny and support submissions to HTA bodies, formulary committees, and health systems.
Study design, database selection, and analytical execution using claims, EHR, and registry data. End-to-end support from hypothesis formation through publication-ready outputs.
Strategic counsel on evidence generation planning, market access positioning, value dossier development, and payer engagement — tailored to your asset’s stage and stakeholder landscape.
PRISMA-compliant literature reviews and evidence synthesis to map the clinical and economic evidence base, identify gaps, and support model inputs and value arguments.
Expertise in real-world data assets, data operations, and analytics infrastructure. Advisory support for organizations building or scaling health data capabilities.
Manuscripts, abstracts, posters, and slide decks for ISPOR, AMCP, ASCO, and peer-reviewed journals. Clear, credible scientific storytelling for diverse audiences.
Ready to build a stronger evidence base? Reach out.